It was demonstrated that cytokines and chemokines are overexpressed in aggressive BRCA tumors, and CXCL2, CXCL3, CXCL5, CXCL6, and CXCL8 chemokines are present at higher levels in metastatic cases [24]. This evidence concerns the gene CXCL6 and invasive breast carcinoma.